Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 9 ... research to identify "Best Buys" based on safety, effectiveness, and price for Proton Pump Inhibitors, a class of drugs to treat heartburn and stomach acid reflux. The report found that no ...
2009 NOV 2 ... According to a study from the United States, "Proton pump inhibitors (PPIs) are the most commonly used pharmacological treatment for gastroesophageal reflux ...
2009 NOV 16 ... measure of acidity and reflux). No patient had a history of reflux or was taking proton pump inhibitors within 4 weeks before and 24 hours after ablation. Five patients (16.1%) who presented ...
2009 OCT 19 ... "It is common practice to coadminister proton pump inhibitors with aspirin to diminish the risk of upper gastrointestinal bleeding. This is the first ...
2009 NOV 16 ... traditional non-aspirin NSAIDs changed from 7.7% to 6.8%, Coxibs from 0% to 0.7%, and proton pump inhibitors (PPIs) from 2.4% to 7.4%. The proportion of subjects on prescription NSAIDs on PPIs ...
2009 NOV 2 ... plan in the United States." "We identified filled prescriptions for oral proton pump inhibitors (PPIs) or histamine-2 receptor antagonists (H2RAs) within 365 days after the index date ...
2009 OCT 12 ... strategies has been demonstrated." "We investigated the utilization of proton pump inhibitors (PPIs) in high risk, short term users of NSAIDs and assessed the association between ...
2009 NOV 9 ... subjects with severe erosive esophagitis (LA Grade C and D). For optimal efficacy, proton pump inhibitors (PPIs) are taken on an empty stomach 20 to 60 minutes before a meal, which can be ...
2009 NOV 9 ... refractoriness of gastric infection to triple therapy (antibiotics, antimicrobials, and proton pump inhibitors). The aim of this study was to evaluate the efficiency of combined periodontal and ...
2009 NOV 16 ... published their study in American Journal of Managed Care (Impact of Compliance With Proton Pump Inhibitors on NSAID Treatment. American Journal of Managed Care, 2009;15(10):681-688). ...
2009 NOV 2 ... resolution rates than those with nonerosive reflux disease (NERD) when treated with proton pump inhibitors (PPIs)," researchers in the United States report. "This open-label ...
2009 NOV 23 ... 95% CI 1.16-4.71). We found no such association when we replicated the analysis using proton pump inhibitors as a neutral exposure. Despite hospitalization for bradycardia, more than half of the ...
2009 NOV 16 ... resistance, suggesting the active export of the compounds by use of the transmembrane proton and electrochemical gradients as sources of energy. In addition, the P55 efflux pump ... clofazimine, which are first- and second-line antituberculosis drugs. The efflux pump inhibitors carbonyl cyanide m-chlorophenylhydrazone (CCCP) and valinomycin inhibited the ...
2009 NOV 2 ... According to a study from Paris, France, "Proton pump inhibitors (PPIs) cost the French health care system >(sic)1 billion in 2005, and similar to 50% ...
2009 OCT 19 ... in Korea.' According to a study from Seoul, Korea, "The lowest effective dose of proton pump inhibitors (PPI) for prevention of peptic ulcer rebleeding remains unclear. The objective of the ...
2009 NOV 1 ... can be caused or alleviated by drug therapy." "GI medications, such as proton pump inhibitors and histamine-2 receptor antagonists, are among the most commonly used medications in ...
2009 OCT 21 ... According to recent research published in the journal Lancet, "Proton-pumpinhibitors (PPIs) are often prescribed in combination with thienopyridines. ...
2009 NOV 2 ... "The 2005 ACG guidelines for the management of dyspepsia recommend eradication and proton pump inhibitors for patients who are H. pylori-positive and-negative, respectively. To establish ...
